European journal of obstetrics, gynecology, and reproductive biology · 2006
Plasma homocysteine and polycystic ovary syndrome: the missed link.
Контролируемое клиническое исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Badawy Ahmed, State Omnia, El Gawad Soma Sh Abd, El Aziz Omar Abd
Аннотация
OBJECTIVE: The objective was to investigate the relationship between insulin resistance and increased serum homocysteine in women with polycystic ovarian syndrome (PCOS).
DESIGN: Prospective controlled trial.
SETTING: Department of Obstetrics & Gynecology, Mansoura Faculty of Medicine, Mansoura, Egypt.
PATIENTS: Ninety PCOS women as a study group and 35 women with infertility due to other causes as a control group.
OUTCOME MEASURES: Serum homocysteine levels in the presence and absence of insulin resistance in PCOS patients.
RESULTS: Homocysteine levels were significantly higher in PCOS patients than in the controls. Considering 11 micromol/l as the cut-off level for a normal homocysteine level, 41.1% of PCOS patients (37 out of 90) and 2.9% of control group (1 out of 35) had high homocysteine levels. With regard to insulin resistance, 23% of PCOS patients without insulin resistance (9 out of 39) had a high homocysteine level, while 47% of PCOS patients with insulin resistance (24 out of 51) had this, thus demonstrating the effect of insulin resistance on the homocysteine level.
CONCLUSION: There is a strong association between serum homocysteine and insulin resistance in women with PCOS that contributes to the long-term complications of PCOS.
DESIGN: Prospective controlled trial.
SETTING: Department of Obstetrics & Gynecology, Mansoura Faculty of Medicine, Mansoura, Egypt.
PATIENTS: Ninety PCOS women as a study group and 35 women with infertility due to other causes as a control group.
OUTCOME MEASURES: Serum homocysteine levels in the presence and absence of insulin resistance in PCOS patients.
RESULTS: Homocysteine levels were significantly higher in PCOS patients than in the controls. Considering 11 micromol/l as the cut-off level for a normal homocysteine level, 41.1% of PCOS patients (37 out of 90) and 2.9% of control group (1 out of 35) had high homocysteine levels. With regard to insulin resistance, 23% of PCOS patients without insulin resistance (9 out of 39) had a high homocysteine level, while 47% of PCOS patients with insulin resistance (24 out of 51) had this, thus demonstrating the effect of insulin resistance on the homocysteine level.
CONCLUSION: There is a strong association between serum homocysteine and insulin resistance in women with PCOS that contributes to the long-term complications of PCOS.